Researchers have developed an inhalable RNA-based drug that targets the overactive white blood cells that cause lung damage during severe infection, reducing inflammation and scarring. With human clinical trials expected next year, the drug may soon be available as a novel treatment for COVID complications and pneumonia.Continue ReadingCategory: Medical, ScienceTags: Lung, Infections, Inflammatory, MicroRNA, Technical University Munich
Inhaled drug reduces lung damage by targeting overactive immune cells
Posted by ArielTechGeek 581 days ago (https://newatlas.com)
Who Voted for this Story
Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz
a
adventure
apps
architects
architecture
best
chrome
clear
compelling
comprehensive
design
electric
follow
fun
game
games
google
guide
hidden
home
hosting
house
ios
its
list
london
money
mysql
nikon
olympics
plenty
projector
providers
save
secret
studio
text
top
tops
view
Comments